Morning-after pill in Morocco: Navela, Postinor — 2026 guide

01How the morning-after pill actually works#

Emergency oral contraception, commonly known in medical circles and the wider public as the "morning-after pill", is a hormonal medicine used to prevent unwanted pregnancy after unprotected intercourse or contraceptive failure (condom rupture, missed daily pill, IUD expulsion, miscalculation of the fertile window). Contrary to a persistent and widespread public misconception, this medicine is neither an abortifacient nor the abortion pill RU-486 (mifepristone), which is reserved for the voluntary termination of pregnancy and is not freely sold in Morocco. The morning-after pill acts upstream, before any pregnancy is established, and has no effect once embryonic implantation in the uterine lining is complete.

The primary mechanism of action of this treatment is the delay or prevention of ovulation. When taken in the phase preceding the luteinising hormone (LH) surge, it prevents rupture of the ovarian follicle and thus the release of the egg. Levonorgestrel, the active ingredient in Navela and Postinor marketed in Morocco, is a synthetic progestogen effective as long as the LH surge has not started. Once that surge has begun, its efficacy drops considerably, which explains why it sometimes fails when taken very close to the moment of ovulation. Ulipristal acetate (EllaOne) is a selective progesterone receptor modulator (SPRM) that works by directly blocking progesterone receptors in the hypothalamus and the pituitary gland, retaining activity even after the LH surge has begun, which gives it a wider window of efficacy within the menstrual cycle.

The cumulative evidence published by the World Health Organization, the French ANSM and the Haute Autorité de Santé (HAS) is unequivocal: if conception has occurred and the embryo is in the process of implanting, emergency contraception has no effect on the course of the pregnancy and does not expose the foetus to any documented malformation risk.

It is also essential to understand that this treatment does not protect intercourse that follows the dose. Once levonorgestrel or ulipristal has been absorbed, it ceases to act within a few days. Any subsequent unprotected intercourse, even hours later, can lead to pregnancy. For this reason, the morning-after pill never replaces a regular contraceptive method and must remain an exceptional fallback rather than a routine. Finally, emergency contraception offers no protection against sexually transmitted infections (HIV, hepatitis B, syphilis, chlamydia, gonorrhoea, human papillomavirus HPV, herpes). After at-risk intercourse, STI screening and, if HIV risk is established (known seropositive partner, sexual assault), antiretroviral post-exposure prophylaxis (PEP) within 48 hours must be discussed urgently in a specialised hospital service.

0212, 72 or 120 hours: why every hour counts#

The golden rule of emergency contraception is unique and can be summarised in a few words: the sooner the better. Efficacy falls hour by hour, and the decline is not linear. According to the meta-analyses published by the French Haute Autorité de Santé and endorsed by the WHO, levonorgestrel taken within the first 12 hours following intercourse prevents about 95 % of expected pregnancies. That rate falls to 85 % between the 24th and 48th hour, then to about 58 % between the 49th and 72nd hour. Beyond 72 hours, levonorgestrel is no longer considered effective by ANSM.

Ulipristal acetate offers a wider window. It retains significant efficacy up to 120 hours (5 days) after intercourse. Within the shared 72-hour window, the randomised comparative trial published by Glasier et al. in The Lancet in 2010 and adopted by HAS suggests that ulipristal is significantly superior to levonorgestrel, particularly in women who are overweight and when the dose is taken close to ovulation. Between 72 and 120 hours, it becomes the only effective oral option.

A third option, often overlooked, is the urgent insertion of a copper IUD within 5 days of intercourse. This is technically the most effective method of all, with a success rate above 99 % according to FIGO emergency contraception guidance and the WHO Medical Eligibility Criteria for Contraceptive Use 2015. It requires a rapid gynaecological consultation and immediate insertion, which in practice limits its accessibility in Morocco outside major cities. The advantage is twofold: immediate protection against the current pregnancy risk and ongoing contraception for 5 to 10 years.

In practice, a woman who suspects she has been exposed to a pregnancy risk should not wait to assess the situation. If the pharmacy is open, it is better to buy and take Navela 1.5 mg that night than wait until morning — the full fact sheet, dosing, real-time price and availability are detailed on /medicaments/navela-1-5-mg-comprime. If intercourse occurred more than 72 hours ago, the correct step is to request EllaOne on prescription or to consult a gynaecologist urgently to discuss copper IUD insertion. These choices depend on context (cycle phase, body mass index, other ongoing treatments) and a Sahha Live teleconsultation with a gynaecologist can prevent a mistake, obtain an EllaOne prescription in less than an hour, and refer to a hospital service if needed.

03Navela, Postinor and EllaOne: comparative table#

The Moroccan market currently includes three main oral emergency contraception products, two based on levonorgestrel and one on ulipristal. Their profiles differ in window of efficacy, regulatory status and price. For full dosage, complete contraindications and verified real-time prices, please refer to the corresponding medicine fact sheets.

Navela 1.5 mg, marketed by Pharma 5 laboratories and widely available in every pharmacy in Morocco, contains 1.5 mg of levonorgestrel in a single tablet to be taken as a single oral dose, as soon as possible after intercourse. The single-tablet presentation has replaced the old regimen of two tablets 12 hours apart. Navela is delivered without prescription in Morocco, in line with the Ministry of Health decision aligned with international recommendations.

Postinor (or Postinor-2) is still available in some Moroccan pharmacies, generally in a single-tablet presentation dosed at 1.5 mg. Its composition and efficacy are identical to Navela: bioequivalent and interchangeable.

EllaOne (ulipristal acetate 30 mg) is marketed by HRA Pharma laboratories. Dosing: one 30 mg tablet as a single oral dose, ideally with some food. It is distinguished by its longer window of efficacy (120 hours), the need for a medical prescription in most Moroccan pharmacies, and a noticeably higher price. Before prescribing, the ulipristal SmPC recommends excluding an ongoing pregnancy by history or pregnancy test.

EllaOne contraindications: hypersensitivity to ulipristal; severe asthma not controlled by oral corticosteroids; severe hepatic impairment; confirmed pregnancy.

Breastfeeding: a major piece of information often overlooked and essential in Morocco where extended breastfeeding is common. Levonorgestrel (Navela, Postinor): compatible with continued breastfeeding. Transfer into breast milk is low and without any documented effect on the infant. Ulipristal (EllaOne): contraindicates breastfeeding for 7 days after intake, per the ANSM SmPC.

Drug interactions — a critical point. Enzyme inducers (phenytoin, carbamazepine, phenobarbital, rifampicin, efavirenz, St John's Wort) significantly reduce the efficacy of levonorgestrel and ulipristal. The SmPC recommends doubling the levonorgestrel dose to 3 mg or preferring a copper IUD.

Ulipristal / hormonal contraception interaction: after EllaOne, wait 5 full days before (re)starting any hormonal contraception and use a condom systematically for 5 days.

Finally, levonorgestrel and ulipristal must never be taken in the same cycle, as their effects partially cancel each other out.

04Really without a prescription in Morocco?#

Levonorgestrel emergency contraception is officially delivered without medical prescription in every pharmacy in Morocco. In practice, experience varies from one pharmacy to another. In major cities (Casablanca, Rabat, Marrakech, Tangier, Agadir), access is generally smooth and anonymous. In some more traditional pharmacies or in rural areas, women still report refusals, intrusive questions or judgemental behaviour.

It is also worth recalling the specific Moroccan legal context: article 490 of the Penal Code sanctions extramarital intercourse, which creates, for some patients, apprehension about requesting emergency contraception. However, no Penal Code provision sanctions the purchase or use of emergency contraception, and the pharmacist's and doctor's professional secret is absolute on this matter.

If a pharmacy refuses to deliver Navela, several options are available: visit another pharmacy, use a Sahha Live teleconsultation platform which can advise and issue an electronic prescription, or contact the neighbourhood family planning centre.

Minors face greater obstacles. No Moroccan regulatory provision formally prohibits delivery to a minor, but pharmacist practice remains variable.

The case of EllaOne is different: this product generally requires a medical prescription in Morocco.

05Prices and where to buy in 2026#

Prices are relatively uniform across Moroccan territory. For 2026: 35 to 70 dirhams for Navela 1.5 mg, 40 to 80 dirhams for Postinor and 150 to 250 dirhams for EllaOne. A copper IUD in the private sector costs 600 to 1,200 dirhams. It is free under the National Family Planning Programme (PNPF).

AMO coverage is currently limited. Oral emergency contraception is not on the list of medicines reimbursable by ANAM.

On-duty pharmacies remain an essential access point for women facing an emergency at night, on weekends or on public holidays. Online purchases must be strictly avoided: counterfeits documented by Interpol and the WHO.

06Side effects: what to anticipate#

Levonorgestrel emergency contraception is overall very well tolerated. Nausea affects about 15 to 20 % of women, more rarely vomiting (1 to 5 %), fatigue, headaches, dizziness, breast tenderness and moderate abdominal pain.

Impact on the menstrual cycle is the most striking consequence. The next period may come early, on the expected date, or several days to two weeks late. A pregnancy test is recommended if the period has not arrived within three weeks of the dose.

Women who are overweight or obese present reduced levonorgestrel efficacy. Several studies by HRA Pharma and the 2014 ANSM alert showed a reduction in efficacy from a BMI above 25 or a weight above 70 kg.

07What to do if vomiting after taking it#

If vomiting occurs within the three hours following the dose, it is recommended to take a second tablet immediately. Beyond three hours, the active ingredient is considered to have been correctly absorbed and no extra dose is needed.

To limit the risk of vomiting: take the tablet with some food, avoid lying down immediately, avoid alcohol. Metoclopramide is the reference antiemetic. Domperidone is now under use restrictions since the 2014 ANSM alert on cardiac risk.

08When to consult a doctor or gynaecologist#

Any period delay greater than three weeks requires a urine pregnancy test. Any severe and persistent abdominal pain must prompt the exclusion of an ectopic pregnancy. Any heavy bleeding justifies a rapid consultation.

A consultation with a sexologist or psychologist may be beneficial after non-consensual intercourse, sexual assault or partner pressure. Emergency contraception must in such cases be accompanied by STI screening and antiretroviral post-exposure prophylaxis (PEP) within 48 hours.

Teleconsultation is particularly suited to these situations. Sahha Live makes it possible to obtain in less than an hour a confidential medical opinion from a certified gynaecologist.

09What next? Choosing a suitable long-term contraception#

The morning-after pill is a safety net, not a contraceptive strategy. Long-acting reversible contraception methods (LARC: implant, copper IUD, hormonal IUD) are now first-line recommendations from the WHO and the Moroccan Society of Gynaecology and Obstetrics due to their superior real-world efficacy (99.2 to 99.95 %).

The Nexplanon implant lasts 3 years for about 1,500 dirhams. The copper IUD lasts 5 to 10 years and is free in the public sector. The hormonal IUD Mirena or Kyleena lasts 5 to 8 years for 800 to 1,500 dirhams.

The condom remains indispensable as a complement to any other method for protection against sexually transmitted infections.

For a comprehensive analysis, the dedicated article Contraception in Morocco 2026 details all options. A conversation with a gynaecologist, in person or via Sahha Live teleconsultation, remains the best way to choose the right method.

Article medically reviewed by Dr. Amina Tazi, gynaecologist and sexologist, on 31 May 2026.

Medical disclaimer: This content is informational and does not in any way replace an individual medical consultation.